Current and future therapeutic approaches for the treatment of small cell lung cancer

被引：36

作者：

Rossi, Antonio ^{[1
]}

Tay, Rebecca ^{[2
]}

Chiramel, Jaseela ^{[2
]}

Prelaj, Arsela ^{[2
,3
]}

Califano, Raffaele ^{[2
,4
,5
]}

机构：

[1] Sci Inst Res & Hlth Care IRCCS Casa Sollievo dell, Div Med Oncol, San Giovanni Rotondo, Italy

[2] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[3] Sapienza Univ Rome, Dept Radiol Pathol & Oncol Sci, Rome, Italy

[4] Manchester Univ NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[5] Univ Manchester, Div Canc Sci, Manchester, Lancs, England

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2018年 / 18卷 / 05期

关键词：

Durvalumab; immunotherapy; ipilimumab; nivolumab; pembrolizumab; rovalpituzumab tesirine; SCLC; second-line; targeted therapy; tremelimumab; PHASE-III TRIAL; PROPHYLACTIC CRANIAL IRRADIATION; PACLITAXEL PLUS BEVACIZUMAB; PLACEBO-CONTROLLED TRIAL; ANTIBODY-DRUG CONJUGATE; DOUBLE-BLIND; OPEN-LABEL; 2ND-LINE TREATMENT; THORACIC RADIOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.1080/14737140.2018.1453361

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: Small-cell lung cancer (SCLC) is a very aggressive disease characterized by a high response rate to first-line chemotherapy, but most patients relapse within 1year with disappointing results to second-line treatments. Chemotherapy has reached a plateau of effectiveness and new therapeutic strategies are needed to change the natural history of SCLC.Areas covered: This review will focus on the current results and the future development of the therapeutic approaches for the treatment of SCLC.Expert commentary: Immunotherapy is becoming a new frontier for the management of SCLC with preliminary interesting results. To date, no targeted drugs have been approved for clinical practice but several novel agents are in an advanced stage of clinical development in SCLC.

引用

页码：473 / 486

页数：14

共 50 条

[21] Advances in Small Cell Lung Cancer
Kalemkerian, Gregory P.
Schneider, Bryan J.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 143 - +
[22] Non-small cell lung cancer: current treatment and future advances
Zappa, Cecilia
Mousa, Shaker A.
TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (03) : 288 - 300
[23] The Current Role of Radiotherapy in the Treatment of Small Cell Lung Cancer
Woolf, D. K.
Slotman, B. J.
Faivre-Finn, C.
CLINICAL ONCOLOGY, 2016, 28 (11) : 712 - 719
[24] Novel Therapeutic Options for Small Cell Lung Cancer
Canova, Stefania
Trevisan, Benedetta
Abbate, Maria Ida
Colonese, Francesca
Sala, Luca
Baggi, Alice
Bianchi, Sofia Paola
D'Agostino, Anna
Cortinovis, Diego Luigi
CURRENT ONCOLOGY REPORTS, 2023, 25 (11) : 1277 - 1294
[25] Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives
Rice, Shawn J.
Miller, Bruce
Wagman, Matthias
Jamorabo, Daniel S.
Liu, Xin
Belani, Chandra P.
CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 183 - 195
[26] The optimal treatment approaches for stage I small cell lung cancer
Moreno, Amy C.
Lin, Steven H.
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (01) : 88 - 96
[27] Emerging therapies for small cell lung cancer
Yang, Sen
Zhang, Zhe
Wang, Qiming
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[28] Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies
McNamee, Nicholas
da Silva, Ines Pires
Nagrial, Adnan
Gao, Bo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
[29] Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer
Saxena, Ashish
SEMINARS IN CANCER BIOLOGY, 2023, 90 : 45 - 56
[30] Advancing immunotherapy in small cell lung cancer
Carlisle, Jennifer W.
Leal, Ticiana
CANCER, 2023, 129 (22) : 3525 - 3534

← 1 2 3 4 5 →